Tocilizumab versus the COVID-19 tempest: all's well that ends well or much ado about nothing?
Academic Article
- Overview
- Identity
- View All
Overview
status
publication date
- September 2020
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Microbiology (Science Metrix)